Understanding the impact on digestive disease in the post-COVID-19 condition: Editorial on "Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK".
作者信息
Baek Yang-Hyun
机构信息
Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
出版信息
Clin Mol Hepatol. 2025 Jan;31(1):319-322. doi: 10.3350/cmh.2024.0856. Epub 2024 Oct 7.
Abstract
摘要
相似文献
1
Understanding the impact on digestive disease in the post-COVID-19 condition: Editorial on "Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK".了解新冠疫情后对消化系统疾病的影响：关于“新冠疫情的长期胃肠和肝胆结局：一项来自韩国、日本和英国的基于多国人群的队列研究”的社论
Clin Mol Hepatol. 2025 Jan;31(1):319-322. doi: 10.3350/cmh.2024.0856. Epub 2024 Oct 7.
2
Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK.长期胃肠道和肝胆道结局的 COVID-19：来自韩国、日本和英国的一项基于多国人群的队列研究。
Clin Mol Hepatol. 2024 Oct;30(4):943-958. doi: 10.3350/cmh.2024.0203. Epub 2024 Aug 29.
3
Correspondence to editorial on "Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: a multinational population-based cohort study from South Korea, Japan, and the UK".致关于“COVID-19的长期胃肠道和肝胆结局：一项来自韩国、日本和英国的基于多国人群的队列研究”的社论的信函。
Clin Mol Hepatol. 2025 Jan;31(1):e87-e89. doi: 10.3350/cmh.2024.0935. Epub 2024 Oct 29.
4
Reply to correspondence on "Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK".对关于“COVID-19的长期胃肠道和肝胆结局：一项来自韩国、日本和英国的基于多国人群的队列研究”的通信的回复
Clin Mol Hepatol. 2025 Jan;31(1):e123-e124. doi: 10.3350/cmh.2024.0966. Epub 2024 Nov 6.
5
Risks of cutaneous immune-related adverse events in long COVID: Multinational cohort studies in South Korea, Japan, and the UK.长新冠皮肤免疫相关不良事件风险：韩国、日本和英国的多国队列研究。
J Med Virol. 2024 Jun;96(6):e29740. doi: 10.1002/jmv.29740.
6
Incident allergic diseases in post-COVID-19 condition: multinational cohort studies from South Korea, Japan and the UK.新冠后(post-COVID-19)条件下的偶发过敏疾病：来自韩国、日本和英国的多国队列研究。
Nat Commun. 2024 Apr 2;15(1):2830. doi: 10.1038/s41467-024-47176-w.
7
COVID-19 and Gastrointestinal and Hepatobiliary Diseases.新型冠状病毒肺炎与胃肠道和肝胆疾病
Pediatr Ann. 2021 Aug;50(8):e315-e319. doi: 10.3928/19382359-20210721-02. Epub 2021 Aug 1.
8
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.与严重冠状病毒感染相关的精神和神经精神症状表现：一项系统综述和荟萃分析，并与新冠疫情进行比较
Lancet Psychiatry. 2020 Jul;7(7):611-627. doi: 10.1016/S2215-0366(20)30203-0. Epub 2020 May 18.
9
Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study.接种2剂2019冠状病毒病疫苗后感染严重急性呼吸综合征冠状病毒2的人群中出现长期新冠症状的风险：基于社区的匹配队列研究
Open Forum Infect Dis. 2022 Sep 12;9(9):ofac464. doi: 10.1093/ofid/ofac464. eCollection 2022 Sep.
10
Editorial: Long COVID, or Post-COVID Syndrome, and the Global Impact on Health Care.社论：长新冠，或新冠后综合征，以及其对全球医疗保健的影响。
Med Sci Monit. 2021 Jun 7;27:e933446. doi: 10.12659/MSM.933446.
引用本文的文献
1
Reply to correspondence on "Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK".对关于“COVID-19的长期胃肠道和肝胆结局：一项来自韩国、日本和英国的基于多国人群的队列研究”的通信的回复
Clin Mol Hepatol. 2025 Jan;31(1):e123-e124. doi: 10.3350/cmh.2024.0966. Epub 2024 Nov 6.
2
Correspondence to editorial on "Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: a multinational population-based cohort study from South Korea, Japan, and the UK".致关于“COVID-19的长期胃肠道和肝胆结局：一项来自韩国、日本和英国的基于多国人群的队列研究”的社论的信函。
Clin Mol Hepatol. 2025 Jan;31(1):e87-e89. doi: 10.3350/cmh.2024.0935. Epub 2024 Oct 29.
本文引用的文献
1
Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK.长期胃肠道和肝胆道结局的 COVID-19：来自韩国、日本和英国的一项基于多国人群的队列研究。
Clin Mol Hepatol. 2024 Oct;30(4):943-958. doi: 10.3350/cmh.2024.0203. Epub 2024 Aug 29.
2
The association of three vaccination doses with reduced gastrointestinal symptoms after severe acute respiratory syndrome coronavirus 2 infections in patients with inflammatory bowel disease.炎症性肠病患者感染严重急性呼吸综合征冠状病毒2后，三剂疫苗接种与胃肠道症状减轻之间的关联。
Front Med (Lausanne). 2024 Mar 18;11:1377926. doi: 10.3389/fmed.2024.1377926. eCollection 2024.
3
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition.接种新型冠状病毒2型（SARS-CoV-2）疫苗可能减轻白细胞介素-1（IL-1）/白细胞介素-18（IL-18）的失调以及新冠后状况的胃肠道症状。
NPJ Vaccines. 2024 Feb 5;9(1):23. doi: 10.1038/s41541-024-00815-1.
4
Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals.健康个体和免疫功能低下个体接种新冠疫苗后肠道微生物群的稳定性
Life Sci Alliance. 2024 Feb 5;7(4). doi: 10.26508/lsa.202302529. Print 2024 Apr.
5
Prolonged Gastrointestinal Manifestations After Recovery From COVID-19.COVID-19 康复后长期的胃肠道表现。
Clin Gastroenterol Hepatol. 2024 May;22(5):1098-1107.e3. doi: 10.1016/j.cgh.2023.11.009. Epub 2023 Nov 22.
6
Long-term gastrointestinal outcomes of COVID-19.新型冠状病毒肺炎的长期胃肠道结果。
Nat Commun. 2023 Mar 7;14(1):983. doi: 10.1038/s41467-023-36223-7.
7
Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis.新冠长期症状的胃肠道表现：一项系统评价与荟萃分析
Therap Adv Gastroenterol. 2022 Aug 19;15:17562848221118403. doi: 10.1177/17562848221118403. eCollection 2022.
8
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis.新型冠状病毒疫苗在炎症性肠病患者中的安全性：系统评价和荟萃分析。
Dig Liver Dis. 2022 Jun;54(6):713-721. doi: 10.1016/j.dld.2022.03.005. Epub 2022 Mar 22.
9
A clinical case definition of post-COVID-19 condition by a Delphi consensus.德尔菲共识对新冠后状况的临床病例定义。
Lancet Infect Dis. 2022 Apr;22(4):e102-e107. doi: 10.1016/S1473-3099(21)00703-9. Epub 2021 Dec 21.
10
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement.炎症性肠病患者的 SARS-CoV-2 疫苗接种：英国胃肠病学会炎症性肠病分会和 IBD 临床研究小组立场声明。
Lancet Gastroenterol Hepatol. 2021 Mar;6(3):218-224. doi: 10.1016/S2468-1253(21)00024-8. Epub 2021 Jan 26.
Zotero 插件